1.. INTRODUCTION {#s1}
================

Acute respiratory infections (ARI) are considered one of the foremost public health problems \[[@B1]\] and are the leading cause for morbidity and mortality in several developing countries \[[@B2]\]. They have been estimated to cause 18--33% of all deaths of children below five years. Half of deaths in developing countries is among children under five years of age \[[@B3]\]; this is 10--50 times more than developed countries with the same ARI cause \[[@B4]\]. Acute respiratory infections (ARI) in children constitute approximately 30--60% of PHC visits around the world; they cause 20--30% of hospital admissions \[[@B5]\]. At least one respiratory virus is found in 15% of hospitalized children \[[@B6]\]. Pneumonia is responsible for more deaths of children than other illnesses -- more than HIV, malaria and measles combined \[[@B7]\]. In addition, it is one of the commonest reasons for visits to the primary care physician \[[@B8]\]. The prevalence of acute respiratory infection in children is 24% in Saudi Arabia \[[@B9]\]. The causes for ARIs vary from self-limiting conditions such as the common cold to the more serious bacterial pneumonia. Even though the majority of cases are viral \[[@B10]--[@B12]\], three-quarters of antibiotics consumed are for ARIs, which has contributed to the emergence of drug-resistant bacterial pathogens, serious side effects, and a significant waste of health care resources \[[@B8]\]. An important concern is the inappropriate use of antibiotics for non-bacterial infections and for self-limiting clinical conditions \[[@B13]\]. The prescription of antibiotic in primary health care centers (PHC) is high \[[@B14]\]. Some of the studies reported antibiotic prescription as high as, 66%, 58.8% and 56% \[[@B15]--[@B18]\]. Despite the very fact that the majority infections treated at this level of care are of self-limiting in nature \[[@B19]--[@B21]\], there's an overuse of antimicrobial treatments \[[@B22]--[@B24]\]. Therefore, assessing healthcare providers prescribing patterns is essential, as there is limited data regarding this issue \[[@B25]\].

Another matter of concern is of prescribed antibiotic \[[@B26]--[@B29]\]. This has serious consequences: exposing the patients to adverse effects, increase of number of visits for mild issues \[[@B14],[@B26],[@B30]\], and development of resistant bacterium strains \[[@B14],[@B31]\]. Infections caused by resistant bacterium are related to bigger morbidity and mortality rates, and health care resources wasting. \[[@B30],[@B32]\].

The World Health Organization (WHO) has developed a protocol for the management of ARI, particularly for developing countries such as Saudi Arabia, the protocol includes the revised recommendations: A) Children with fast breathing pneumonia with no chest in drawing or general danger sign should be treated with oral amoxicillin. B) Children age 2--59 months with chest in drawing pneumonia should be treated with oral amoxicillin C) Children aged 2--59 months with severe pneumonia should be treated with parenteral ampicillin (or penicillin) and gentamicin as a first-line treatment. D) Ampicillin (or penicillin when ampicillin is not available) plus gentamicin or ceftriaxone are recommended as a first-line antibiotic regimen for HIV-infected and -exposed infants and for children under 5 years of age with chest in drawing pneumonia or severe pneumonia. E) Empiric cotrimoxazole treatment for suspected Pneumocystis jirovecii (previously Pneumocystiscarinii) pneumonia (PCP) is recommended as an additional treatment for HIV-infected and -exposed infants aged from 2 months up to 1 year with chest in drawing or severe pneumonia. F) Empirical cotrimoxazole treatment for Pneumocystis jirovecii pneumonia (PCP) is not recommended for HIV-infected and -exposed children over 1 year of age with chest in drawing or severe pneumonia. \[[@B33]\]. This study was conducted to observe the pattern of physicians' prescriptions, to determine their practices related to ARI management and compliance with WHO protocols, and to provide recommendations to enhance their practices in primary health care centers.

2.. METHODS {#s2}
===========

2.1.. Study Setting {#s2.1}
-------------------

The study was conducted in Primary Health Care Centres (PHC) of Makkah Al Mukarramah, Saudi Arabia.

2.2.. Study Design {#s2.2}
------------------

A cross-sectional study, conducted from 1/2/2016 to 31/3/2016.

2.3.. Sample Size {#s2.3}
-----------------

The sample size was calculated using the online software of Epi Info, developed by the Centers for Disease Control and Prevention (CDC), using a confidence level of 95%. As our technique was cluster sampling we chose a design effect of 2.0. The estimated sample size was 769. An additional 20% (154) was added to account for dropouts, because of possibility of refusal of any PHC physician to participate in the study with a final total of 923. (For details please, see [Appendix A](#APP1){ref-type="app"} below).

2.4.. Sampling Procedure {#s2.4}
------------------------

The sampling technique used was Multistage cluster sampling, to select PHC centers during the first phase of the study, then to select registered physicians in the second phase of the study and then later to select their prescriptions. After obtaining the list of all PHC centers of Makkah from the Ministry of Health, we randomly selected 20% of the PHC centers with the help of Statistical Package for the Social Sciences software (SPSS) version 21. As there are 70 PHC centers in Makkah, a total 14 PHC centers were selected. From each selected PHC center we randomly selected general practitioners and from each physician we randomly selected their prescriptions for ARI. After obtaining their consent, a total of 908 prescriptions were collected by going to clinic daily and collecting the prescriptions. We compared the prescriptions with WHO guidelines recommendations for acute respiratory infections \[[@B33]\]. The main variables assessed, beside basic demographic characteristics, included: chief complaints, temperature, pulse rate, respiratory rate, provisional diagnosis and the type of antibiotic prescribed. All variables were entered into the computer and analyzed by SPSS version 21.

The protocol was submitted to IRB of College of Medicine and ethical approval was obtained as HAPO-02-K-012-2016-02-142.

3.. RESULTS {#s3}
===========

A total of 923 prescriptions were planned, whereas 908 prescriptions were collected, as one of the physician refused to participate in the study. The majority of children, 558/908 (61.5%), were seen in public PHC centers and 350/908 (38.5%) of them were in private PHC centers. By gender, more than half of the cases were males i.e. 522/908 (57.5%) and females accounted for 386/908 (42.5%). ([Table 1](#T1){ref-type="table"}).

###### 

Profile of children presenting to PHCs with acute resiratory infection, Makkah, KSA, 2016.

  **Variables**                                                                    **Number of cases**   **Percentage (%)**
  -------------------------------------------------------------------------------- --------------------- --------------------
  Age (Years)                                                                                            
    Less than 1                                                                    69                    (7.6%)
    1--5                                                                           289                   (31.8%)
    6--10                                                                          258                   (28.4%)
    11--15                                                                         161                   (17.7%)
    16--18                                                                         131                   (14.4%)
    More than 18                                                                   0                     (0%)
  Gender                                                                                                 
    Male                                                                           522                   (57.5%)
    Female                                                                         386                   (42.5%)
  Type of center                                                                                         
    Public                                                                         558                   (61.5%)
    Private                                                                        350                   (38.5)
  Chief complaint                                                                                        
    Fever                                                                          120                   120 (13.2%)
    Cough                                                                          75                    75 (8.3%)
    Runny nose                                                                     24                    24 (2.6%)
    Sore throat                                                                    13                    13 (1.4%)
    More than one respiratory symptom                                              569                   569 (62.7%)
    Others                                                                         68                    (7.5%)
    Not written                                                                    39                    (4.3%)
  Physical examination                                                                                   
    Congested throat                                                               121                   (13.3%)
    Ear problems                                                                   51                    (5.6%)
    Pharyngeal tonsillar erythema                                                  99                    (10.9%)
    Tonsillar exudate                                                              35                    (3.9%)
    More than one respiratory finding                                              188                   (20.7%)
    Others                                                                         55                    (6.1%)
    Not written                                                                    359                   (39.5%)
  Clinical diagnosis                                                                                     
    Pneumonia with tachypnea, with no costal retractions or general danger signs   15                    (1.7%)
    Pneumonia with costal retractions                                              5                     (0.6%)
    Severe pneumonia                                                               1                     (0.1%)
    Common cold                                                                    227                   (25.0%)
    Upper respiratory tract infection                                              103                   (11.3%)
    Allergic asthma                                                                11                    (1.2%)
    Tonsillitis and pharyngitis                                                    35                    (3.9%)
    Bronchial asthma                                                               11                    (1.2%)
    Pharyngitis                                                                    123                   (13.5%)
    Lower respiratory tract infection                                              9                     (1.0%)
    Tonsillitis                                                                    104                   (11.5%)
    Otitis media                                                                   56                    (6.2%)
    Otitis externa                                                                 10                    (1.1%)
    Bronchitis                                                                     51                    (5.6%)
    Bronchiolitis                                                                  12                    (1.3%)
    Influenza                                                                      17                    (1.9%)
    Others                                                                         48                    (5.3%)
    Not written                                                                    70                    (7.7%)
  Total                                                                            908                   (100%)

The predominant categories of age were from 1 to 5 years (289/908, 31.8%) and 6--10 years (258/908, 28.4%) ([Table 1](#T1){ref-type="table"}).

Chief complaints were recorded in 869/908 (95.7%) cases. Most common single chief complaint was fever in 120/869 (13.8%), cough in 75/869 (8.6%), rhinorrhea in 24/869 (2.7%), and sore throat in 13/869 (1.4%) cases. More than one respiratory symptom was recorded in 569/869 (65.4%), and other complaints formed 68/869 (7.8%) of all cases. ([Table 1](#T1){ref-type="table"}) Unfortunately, only 550/908 (60.5%) of the paediatric patients were physically examined. Physical examination findings demonstrated: congested throat in 121/550 (22%), ear problems were found in 51/550 (9.3%), pharyngeal tonsillar erythema in 99/550 (18%) tonsillar exudate in 35/550 (6.4%), more than one respiratory finding in 188/550 (34.2%), other findings were found in 55/550 (10%) cases ([Table 1](#T1){ref-type="table"}).

Diagnosis was recorded in 838/908 (92.3%) of cases, with the most common diagnosis being common cold at 227/838 (27.6%), followed by 123/838 cases of pharyngitis (15%), 104/838 Tonsillitis (12.6%) and pneumonia in only 21/838 cases (2.4%). Other diagnoses were noted in 346/838 (42.1%) of cases ([Table 1](#T1){ref-type="table"}).

Pneumonia with tachypnea, without costal retractions or general danger signs, were noted in 15/21 cases (71.4%), pneumonia with costal retractions in 5/21 cases (23.8%) and only 1/21 child suffered from severe pneumonia (4%) ([Table 1](#T1){ref-type="table"}).

684/908 (75.3%) of patients had their weights recorded during their visit. Of the three main vital signs, heart rate was recorded in 602/908 (66.3%), temperature in 764/908 (84.1%) and respiratory rate in 582/908 (64.1%) ([Table 2](#T2){ref-type="table"}).

###### 

Distribution of the recording of various variables required to support a diagnosis.

  **Features recorded**   **Yes**       **No**
  ----------------------- ------------- -------------
  Weight                  684 (75.3%)   224 (24.7%)
  Temperature             764 (84.1%)   144 (15.9%)
  Heart rate              602 (66.3%)   306 (33.7%)
  Respiratory rate        582 (64.1%)   326 (35.9%)
  Chief complaints        869 (95.7%)   39 (4.3%)
  Physical examination    550 (60.6%)   358 (39.4%)
  Provisional diagnosis   838 (92.3%)   70 (7.7%)

Overall, antibiotics were prescribed in 515/908 cases (56.7%), distributed as either a single therapy in 103/515 (20%), a combination of antibiotic and antipyretics in 164/515 (31.8%), or as antibiotics with other drugs in 248/515 (48.1%) ([Fig. 1](#F1){ref-type="fig"}).

![Distribution of choice of children's treatment.](JEGH_8_3-4_149-g001){#F1}

First choice of antibiotic prescribed was Amoxicillin in 275/515 (53.3%) of cases, second choice was Ceftriaxone in 81/515 (15.7%), followed by Augmentin in 45/515 (8.7%), various other antibiotics in 90/515 (17.5%), and lastly more than one antibiotic was prescribed in 14/515 cases (2.7%) ([Fig. 2](#F2){ref-type="fig"}).

![Distribution of the types of antibiotics used.](JEGH_8_3-4_149-g002){#F2}

4.. DISCUSSION {#s4}
==============

In the PHC of Makkah, the incidence of ARI in children under 5 years old was 358 (39.4%). Several studies had a similar incidence of approximately 30--40% in children below 5 years - Al-Khalidi, Ramani, and Peasah \[[@B8],[@B34],[@B35]\]. In contrast, Siddiqui found an ARI incidence of 83.2% \[[@B7]\].

In the majority of studies, including ours, ARI cases consisted of upper respiratory tract infections (URTI). Lower respiratory tract infections (LRTI), such as pneumonia, bronchitis and bronchiolitis, were 10% in our study as well as in Al-Khalidi, and Saeed \[[@B8],[@B34]\]. Sarfraz \[[@B25]\] reported a higher respiratory tract infections rate of 68%.

This study, as well as most other studies, found patients, predominantly, of male gender: Siddiqui, Al-Khalidi, Krishnan, and Dharmage \[[@B7],[@B8],[@B34],[@B36],[@B37]\], in contrast to Acharya \[[@B4]\] where both genders were equivalent. Chandwani \[[@B38]\] reported a male-dominated society as a possible reason.

569 (65.4%) patients presented with more than one respiratory symptom. The single most common complaint was fever, seen in 120 cases (13.8%), with a similar rate reported by Siddiqui \[[@B7]\] and Chandwani \[[@B21]\]. A much higher rate of 98.8% was found in Ramani \[[@B34]\]. Al-Khaldi \[[@B8]\] reported 70% of cases complained of cough.

Vital signs were recorded in this study and in Siddiqui \[[@B7]\] as follows: Temperature 144 (15.9%), 106(52%); Heart rate 306 (33.7%), 177(88%); Respiratory rate 326 (35.9%), 135(67%); and Weight 224 (24.7%), 132(65%), respectively. Al-Khaldi \[[@B8]\] and Ramani \[[@B34]\] did not mention these variables.

Congested throat was the most frequent finding in this study and Al-Khaldi \[[@B8]\]. Interestingly, the rank order of the most common diagnoses was similar between this study and that of Al-Khaldi \[[@B8]\]: Common cold was first (27.6%, 42%), followed by pharyngitis (15%, 25%), and tonsillitis (12.6%, 17%), respectively. This may be due to physician habits within the same nation.

Diagnosis was written in the great majority of PHC cases, in 92.3%, similar to Al-Khaldi \[[@B8]\] at 97.5%. In contrast, in Siddiqui \[[@B7]\] the diagnosis was written in less than half of the cases (44.6%).

The drug of choice was Amoxicillin in 275 (53.3%) of cases, followed by Ceftriaxone in 81 (15.7%), and Augmentin in 45 (8.7%) cases. One of the reason of prescribing, antibiotic other than amoxicillin, as observed by us, was non-availability of amoxicillin, in some of the centers. Siddiqui \[[@B7]\] reported the most common antibiotic prescribed as Amoxicillin in 21.4%, followed by a first generation cephalosporin (19.9%) and co-trimoxazole (14.3%). A recent study in Morocco by Jroundi \[[@B39]\] found the most commonly prescribed antibiotic was a cephalosporin (213/286; 74.5%), followed by macrolides (21%), then Gentamicin (13.6%). Al-Khaldi \[[@B8]\] did not report antibiotic classes. According to revised WHO guidelines, Amoxicillin should be given as first line of treatment and Ceftriaxone as second line of treatment \[[@B33]\].

Our study limitation is the duration of sample collection; it was conducted at the end of the local winter season because of late approval from ethical committee.

5.. CONCLUSION {#s5}
==============

Many physicians in Makkah Al Mukarramah are not following the WHO guidelines for Acute Respiratory Infection. Educational health programs should be conducted to sensitize the physicians as well as patients regarding the appropriate method of diagnosis and rational use of antibiotics \[[@B40]\].
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SAMPLE SIZE FOR FREQUENCY IN A POPULATION
=========================================

1.  Population size (for finite population correction factor or fpc) (*N*): 1600000

2.  Hypothesized % frequency of outcome factor in the population (*p*): 50% ±5

3.  Confidence limits as % of 100(absolute ±%)(*d*): 5%

4.  Design Effect (for cluster surveys-*DEFF*): 2

Sample Size(*n*) for Various Confidence Levels. **Confidence level (%)Sample size**95%76980%32990%54297%94299%132799.9%216599.99%3026 $$\text{Sample}\,\text{size}\,\mathbf{n} = \lbrack\mathbf{DEFF}*\mathbf{Np}(1 - \mathbf{p})\rbrack/\lbrack\mathbf{d}^{2}/\mathbf{Z}_{1 - \alpha/2}^{2}*(\mathbf{N} - 1) + \mathbf{p}*(1 - \mathbf{p})\rbrack$$ Results from OpenEpi, Version 3, open source calculator---SSProporPrint from the browser with ctrl-Por select text to copy and paste to other programs.
